Related Experiment Video
Updated: Feb 23, 2026
Foodborne Pathogen Screening Using Magneto-fluorescent Nanosensor: Rapid Detection of E. Coli O157:H7
Published on: September 17, 2017
State of diagnosing infectious pathogens using colloidal nanomaterials.
Jisung Kim1, Mohamed A Abdou Mohamed2, Kyryl Zagorovsky3
1Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada; Terrence Donnelly Centre for Cellular and Bimolecular Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada; Centre for Global Engineering, University of Toronto, Toronto, Ontario M5S 1A4, Canada.
This review explores nanotechnology-based diagnostics for infectious diseases. Colloidal nanomaterials offer advanced tools for rapid pathogen identification, aiding timely treatment and disease control.
Area of Science:
- Nanotechnology
- Infectious Disease Diagnostics
- Biomedical Engineering
Background:
- Infectious diseases represent a significant global health challenge, causing substantial mortality and morbidity.
- Early and accurate diagnosis is critical for effective disease management, patient isolation, and preventing outbreaks.
- Current diagnostic methods face limitations in speed, sensitivity, and specificity for certain pathogens.
Purpose of the Study:
- To review recent advancements in diagnostic systems utilizing colloidal nanomaterials for infectious pathogen detection.
- To highlight the application of nanomaterials like gold nanoparticles, quantum dots, and magnetic nanoparticles in diagnostics.
- To discuss the challenges and prospects for the clinical implementation of nanotechnology-based diagnostic devices.
Main Methods:
- Literature review of peer-reviewed articles on nanotechnology in infectious disease diagnostics.
- Analysis of studies employing various colloidal nanomaterials for pathogen identification.
- Examination of research focusing on the translation of nanotechnology diagnostics to clinical settings.
Main Results:
- Colloidal nanomaterials demonstrate significant potential for sensitive and specific detection of infectious agents.
- Nanoparticle-based assays offer advantages in speed and multiplexing capabilities compared to traditional methods.
- Emerging nanotechnology diagnostics show promise for point-of-care applications.
Conclusions:
- Nanotechnology offers innovative solutions for improving infectious disease diagnosis.
- Overcoming challenges in clinical translation is key to realizing the full potential of these advanced diagnostic tools.
- Further research and development are needed to integrate nanotechnology diagnostics into routine healthcare.
